Zantac Cancer Plaintiffs Wait For Bellwether Trials To Begin

The identity of scientific experts that will be allowed to testify could help gauge the likelihood of Zantac cancer settlements

Tuesday, January 18, 2022 - Individuals that have relied on Zantac heartburn and acid reflux medicine were shocked when the drug was recalled and the cancer scare became public knowledge. Zantac customers have been diagnosed with several different types of cancer of the intestinal tract and also cancer of the mouth, breast, and now brain. Only several types of common cancer are eligible to join the thousands registered to file a Zantac cancer lawsuit against Sanofi, the maker of the medicine, but individuals with any type of cancer may allege that it was caused by the drug. Qualifying cancers are bladder, colorectal/intestinal, esophageal, gastric, liver, lung, pancreatic, and prostate cancer. Heartburn medicine lawsuits are organized into multidistrict litigation because each plaintiff took the same drug and have developed one of the same types of cancer. What is more important than the type of cancer, however, is that individuals can prove they were either prescribed Zantac or bought it over the counter and took it every day for more than one year. The longer the greater the odds of having developed cancer.

Zantac is the brand name for the generic drug ranitidine which seems to be unstable and breakdown when exposed to high heat. Ranitidine degrades to become N-nitrosodimethylamine (NDMA) a highly carcinogenic substance. The more NDMA one ingests, the greater the odds of developing cancer. Individuals that have filed Zantac cancer lawsuits continue to speculate whether or not Sanofi will offer a settlement after bellwether Zantac cancer trials take place next year, and wonder about the amount of the offer. Other mass tort lawsuits like the one involving Bayer's Roundup herbicide netted plaintiffs 7 figure settlements. 125,000 glyphosate cancer plaintiffs were awarded over $12 billion in the aggregate and Bayer has been forced to set aside over ten billion more for future cancer claims. Zantac cancer could have a latency period of ten or more years before symptoms become evident like glyphosate's non-Hodgkin's lymphoma cancer. A Zantac cancer class action lawsuit is attempting to get Sanofi to pay for permanent, semi-annual cancer medical testing of each Zantac user to catch cancer before it has the time to spread to nearby organs or the entire body through the bloodstream. The longer the cancer patient waits, the greater the odds that the disease will be untreatable and that they will not survive more than a few years.

The growing number of cases, now over 140,000, could break the record and become the largest mass tort lawsuit of all time. More than 15 million people were taking Zanac ranitidine at the time of the product's recall. Sanofi remarketed Zantac ranitidine as Zantac famotidine, an antacid like Pepcid, that is stronger than Zantac ranitidine and lasts longer. Many Zantac users have switched to the new Zantac 360 without knowing the former drug recall. Famotidine has not tested positive for carcinogenic levels of NDMA to date.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.